Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Aug 4, 2021
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2021-08-03$2.40/sh−63$151→ 15,321 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021.